Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patient.
Weir
A
A
Wansbrough-Jones
M
M
D017088:AIDS-Related Opportunistic Infections / Q000139:chemically induced*; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009061:Mouth Mucosa; D009062:Mouth Neoplasms / Q000139:chemically induced* / Q000150:complications; D019438:Ritonavir / Q000009:adverse effects* / Q000627:therapeutic use; D019258:Saquinavir / Q000009:adverse effects* / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000139:chemically induced* / Q000150:complications
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019258:Saquinavir; D019438:Ritonavir